Yoshiyuki Yamamoto Selected Research

Yoshiyuki Yamamoto Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 09/2011
16	Stomach Neoplasms (Stomach Cancer) 10/2023 - 07/2014
14	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 12/2011
13	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 09/2012
13	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2013
12	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2018
12	Carcinoma (Carcinomatosis) 05/2022 - 09/2011
6	Urinary Bladder Neoplasms (Bladder Cancer) 05/2023 - 09/2011
5	Ascites 10/2023 - 01/2017
5	Lymphatic Metastasis 03/2023 - 09/2012
4	Adenocarcinoma 07/2023 - 01/2014
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 05/2015
4	Disease Progression 05/2023 - 01/2021
3	Fever (Fevers) 08/2022 - 01/2013
2	Margins of Excision 02/2024 - 10/2017
2	Hepatitis 01/2024 - 09/2021
2	Body Weight (Weight, Body) 10/2023 - 12/2016
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 12/2020
2	Hyperthermia 07/2023 - 01/2019
2	Signet Ring Cell Carcinoma 04/2023 - 01/2022
2	Anemia 01/2023 - 08/2022
2	Hemorrhage 04/2022 - 09/2013
2	Fistula 04/2022 - 09/2010
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Erythema 11/2018 - 02/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2015 - 01/2013
2	Cardiotoxicity 07/2014 - 07/2013
1	Abdominal Pain (Pain, Abdominal) 01/2024
1	Cytokine Release Syndrome 01/2024
1	Neuroendocrine Carcinoma 10/2023
1	Proteinuria 05/2023
1	Renal Insufficiency (Renal Failure) 04/2023
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 04/2023

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2016
11	NivolumabIBA 10/2023 - 01/2021
8	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 02/2019
8	Bevacizumab (Avastin)FDA Link 03/2024 - 10/2019
6	Cell-Free Nucleic AcidsIBA 01/2024 - 04/2018
6	Circulating Tumor DNAIBA 05/2022 - 02/2019
5	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
5	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 03/2014
4	Monoclonal AntibodiesIBA 10/2023 - 12/2015
4	RamucirumabIBA 10/2023 - 04/2022
4	MicellesIBA 12/2016 - 07/2013
4	Thromboplastin (Tissue Factor)IBA 03/2016 - 05/2015
4	NC 6300IBA 03/2016 - 07/2013
3	cabazitaxel FDA Link 04/2024 - 07/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 10/2019
3	trifluridine tipiracil drug combinationIBA 03/2024 - 01/2023
3	pembrolizumabIBA 01/2024 - 10/2021
3	Immunoglobulin G (IgG)IBA 10/2023 - 12/2015
3	Gemcitabine FDA Link 07/2023 - 11/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2022 - 01/2021
3	Epirubicin (Ellence)FDA LinkGeneric 03/2016 - 07/2013
2	Bacterial DNAIBA 04/2024 - 09/2023
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 10/2019
2	Leucovorin (Folinic Acid)FDA Link 03/2024 - 01/2022
2	Axitinib (AG 013736)IBA 01/2024 - 04/2022
2	Protons (Proton)IBA 07/2023 - 10/2021
2	130-nm albumin-bound paclitaxelIBA 07/2023 - 01/2017
2	Therapeutic UsesIBA 03/2023 - 03/2022
2	Albumin-Bound Paclitaxel FDA Link 12/2022 - 04/2022
2	Capecitabine (Xeloda)FDA Link 08/2022 - 11/2020
2	AndrogensIBA 07/2022 - 10/2013
2	IpilimumabIBA 04/2022 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2022
2	AlbuminsIBA 10/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 07/2021 - 02/2019
2	MicroRNAs (MicroRNA)IBA 04/2021 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 03/2019 - 01/2018
2	AgarIBA 01/2019 - 12/2002
2	Panitumumab (Vectibix)FDA Link 02/2015 - 01/2013
1	16S Ribosomal RNAIBA 04/2024
1	afliberceptIBA 03/2024
1	tocilizumab (atlizumab)FDA Link 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	HaptoglobinsIBA 10/2023
1	avelumabIBA 04/2023
1	nedaplatinIBA 04/2023
1	enzalutamideIBA 03/2023
1	taxaneIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Alkaline PhosphataseIBA 12/2022

Therapy/Procedure

27	Drug Therapy (Chemotherapy) 10/2023 - 12/2011
21	Therapeutics 01/2024 - 12/2011
6	Castration 04/2024 - 07/2019
6	Prostatectomy (Retropubic Prostatectomy) 02/2024 - 07/2014
5	Radiotherapy 10/2023 - 12/2011
4	Nephrectomy 01/2024 - 09/2012
4	Cystectomy 05/2023 - 09/2011
3	Adjuvant Chemotherapy 01/2019 - 07/2013
2	Proton Therapy 07/2023 - 10/2021
2	Urinary Diversion (Ileal Conduit) 05/2023 - 09/2011
2	Neoadjuvant Therapy 05/2023 - 10/2021
2	Immunotherapy 01/2023 - 04/2022
2	Chemoradiotherapy 10/2021 - 10/2020
2	Nephroureterectomy 11/2015 - 02/2015
2	Kidney Transplantation 02/2013 - 02/2013
1	Precision Medicine 02/2024
1	Drug Tapering 01/2024